301206.SZ
三元生物
SZSE · Consumer Defensive · C 制造业 · CN
CNY 23.58
−1.50%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 724.1M | 649.5M | 712.9M | 499.5M | 674.9M |
| Cost of Revenue | 608.4M | 544.8M | 633.7M | 484.3M | 580.0M |
| Gross Profit | 115.6M | 104.7M | 79.2M | 15.2M | 94.9M |
| Operating Expenses | |||||
| R&D Expense | 32.9M | 34.4M | 41.2M | 50.7M | 34.1M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 29.7M | 29.5M | 19.7M | 15.5M | 16.9M |
| Selling & Marketing Expense | 9.5M | 8.4M | 7.0M | 5.6M | 5.2M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 74.4M | 70.9M | 61.0M | 66.6M | 2.9M |
| Cost and Expenses | 682.8M | 615.7M | 694.8M | 550.9M | 583.0M |
| Operating Income (EBIT) | 106.6M | 105.0M | 127.9M | 58.5M | 186.1M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 107.0M | 105.4M | 128.2M | 58.8M | 184.0M |
| Income Tax Expense | 14.5M | 14.1M | 23.3M | 2.8M | 20.3M |
| Bottom Line | |||||
| Net Income | 92.6M | 91.4M | 105.0M | 56.0M | 163.7M |
| Earnings from Cont. Ops | 92.5M | 91.3M | 105.0M | 56.0M | 163.7M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 92.6M | 91.4M | 105.0M | 56.0M | 163.7M |
| Per Share | |||||
| Basic EPS | CN¥0.47 | CN¥0.46 | CN¥0.52 | CN¥0.28 | CN¥0.82 |
| Diluted EPS | CN¥0.47 | CN¥0.46 | CN¥0.52 | CN¥0.28 | CN¥0.82 |
| Revenue Per Share | CN¥3.61 | CN¥3.27 | CN¥3.53 | CN¥2.50 | CN¥3.38 |
| Shares | |||||
| Basic Shares Outstanding | 200.7M | 198.7M | 201.8M | 199.9M | 199.6M |
| Diluted Shares Outstanding | 200.7M | 198.7M | 201.8M | 199.9M | 199.6M |
| Profitability Metrics | |||||
| EBITDA | — | 178.6M | 194.2M | 118.1M | 224.8M |
| D&A | — | 73.5M | 66.3M | 59.6M | 38.7M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026